Russian Federation (RU)

Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival (2025) Crown J, Stroyakovskii D, Yardley DA, Huang CS, Fasching P, Bardia A, Chia S, et al. Journal article Reply to ‘Potential benefit of anticoagulation in Behçet syndrome’ (2025) Fagni F, Bagni G, Bello F, Hill CL, Mohammad AJ, Moiseev S, Olivotto I, et al. Journal article Ribociclib Plus Endocrine Therapy in Hormone Receptor-Positive/ERBB2-Negative Early Breast Cancer: 4-Year Outcomes From the NATALEE Randomized Clinical Trial (2025) Fasching P, Stroyakovskiy D, Yardley DA, Huang CS, Crown J, Bardia A, Chia S, et al. Journal article Hydrogenation of Aromatic Ethers and Lactones: Does the Oxygen Functionality Really Improve the Thermodynamics of Reversible Hydrogen Storage in the Related LOHC Systems? (2025) Siewert R, Samarov AA, Vostrikov SV, Müller K, Wasserscheid P, Verevkin SP Journal article Lymph node mapping-based optimal bowel-resection margin and central radicality in colon cancer surgery: an international, prospective, observational cohort study (2025) Ueno H, Kim NK, Kim JC, Tsarkov P, Hohenberger W, Grützmann R, Samalavičius NE, et al. Journal article Structural and Phase Stability of the Ti3C2Tx MXene at Elevated Temperatures: In-situ X-Ray Diffraction Investigation (2025) Krotkevich D, Kashkarov E, Wang Z, Syrtanov M, Travitzky N, Lider A Conference contribution Evaluation of Nectin-4 and Trop-2: Implications for Patient Outcomes and Therapy in Penile Cancer (2025) Mink JN, Eckstein M, Khalmurzaev O, Pryalukhin A, Geppert CI, Lohse S, Bende K, et al. Journal article Health-Related Quality of Life in Patients with HR+/HER2- Early Breast Cancer Treated with Ribociclib Plus a Nonsteroidal Aromatase Inhibitor: Results from the NATALEE Trial (2025) Fasching P, Slamon D, Nowecki Z, Kukielka-Budny B, Stroyakovskiy D, Yardley DA, Huang CS, et al. Journal article Boosting the Host-Guest Binding by Programming the Curvature in Geodesic Nanoribbons (2025) Oshchepkov AS, Korenkov K, Sarkar S, Papaianina O, Akhmetov V, Ruppenstein C, Troyanov SI, et al. Journal article Risankizumab Is Associated With Normalization of Biomarkers in Patients With Crohn's Disease: Results From the Phase 3 ADVANCE, MOTIVATE, and FORTIFY Studies (2025) Atreya R, Ferrante M, Panaccione R, Feagan B, Shchukina O, Jairath V, Rieder F, et al. Journal article